The Echo Journal

The Echo Journal

Share this post

The Echo Journal
The Echo Journal
Hypertrophic Obstructive Cardiomyopathy: The Truth

Hypertrophic Obstructive Cardiomyopathy: The Truth

A Case Breakdown & Explanation

Aram K.'s avatar
Aram K.
Jan 07, 2025
∙ Paid
3

Share this post

The Echo Journal
The Echo Journal
Hypertrophic Obstructive Cardiomyopathy: The Truth
1
Share

What is HCM?

Hypertrophic cardiomyopathy (HCM) is a rare disease, often inherited, that causes the heart muscle to thicken, or hypertrophy. It affects both genders and many races and cultures around the world; in the general population it is seen in 1:200-1:500 individuals, largely based on the disease phenotype with imaging. HCM is treatable and patients can live a normal life, making early diagnosis a top priority.

The Echo Journal is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber.

Advances in echocardiography and cardiovascular magnetic resonance imaging (CMR) allow clinical teams to identify relatives with the HCM phenotype. On the contrary, genetic analysis can recognize the sarcomere gene carriers that do not have left ventricular hypertrophy but can still transmit the disease (Maron et al, 2022)

Explore a real-world case of Hypertrophic Obstructive Cardiomyopathy (HOCM).
In this lesson, we break down the diagnostic challenges and proper scanning strategies for HOCM. This preview offers a glimpse, but upgrading your membership unlocks full access to the complete case study, expert insights, and interactive learning tools to enhance your understanding.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Echo Imaging Solutions LLC
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share